COMP <GO>
SBRA vs RITM // FORWARD P/E MULTIPLE
Sabra Health Care REIT Inc. (NASDAQ) VS. Rithm Capital Corp. (NYSE) • 15-METRIC TALLY: SBRA 6
— RITM 3
▲ FORWARD P/E MULTIPLE LEADER: RITM
LAST: $20.35 (+3.20%) • MKT CAP: $5.04B
forward-pe
27.0x
LAST: $9.22 (-2.43%) • MKT CAP: $5.28B
forward-pe
8.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SBRA VS. RITM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SBRA | RITM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.50% | 2.20% | +3.30 | SBRA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 25.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.96% | -18.00% | +24.96 | SBRA | /fcf-yield <GO> |
| Operating Margin | — | 15.10% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 43.60% | 12.40% | +31.20 | SBRA | /net-margins <GO> |
| Revenue Growth (YoY) | 25.40% | -6.70% | +32.10 | SBRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.78% | 0.00% | +5.78 | SBRA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 3/9 | +3.00 | SBRA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.3 | 58.9 | -5.60 | RITM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.00 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 27.0x | 8.6x | +18.40 | RITM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.04B | $5.28B | -$239.2M | RITM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SBRA REV | RITM REV | SBRA GROSS % | RITM GROSS % | SBRA FCF | RITM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $356.9M | $4.59B | — | — | $348.6M | -$1.50B |
| FY 2024 | $284.6M | $4.92B | — | — | $310.5M | -$2.41B |
| FY 2023 | $236.2M | $3.68B | — | — | $300.6M | $528.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SBRA // BETA —
RITM // BETA 1.00